Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 or older
- People whose breast cancer was classified at a advanced local stage (spread to nearby tissue or lymph nodes) before treatment, regardless of hormone receptor type
- People whose cancer tested positive for HER2, confirmed by specific laboratory tests (IHC 3+, or IHC 2+ with ISH+)
- People whose cancer completely disappeared (no cancer cells found) after pre-surgery treatment, known as a pathological complete response
- People who have finished one full year of standard post-surgery treatment (including the drug trastuzumab), with no more than 6 months having passed between the last treatment and starting the trial drug (neratinib)
- People with no signs of cancer returning or spreading, confirmed by clinical checks and imaging after completing standard post-surgery treatment and before starting the trial drug
- People whose heart is pumping at 50% efficiency or above, as measured by a specific heart scan (LVEF ≥50%)
- People who are physically well enough to carry out daily activities with no or only minor limitations (confirmed with trial site)
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had an allergic reaction to any ingredient in the trial drug
- People who are unable to swallow tablets or oral medication
- People who have taken part in another interventional clinical trial within the 4 weeks before enrolling, or who plan to do so during this study
- People who have used any experimental drug within 14 days before starting treatment
- People currently receiving chemotherapy, radiotherapy, immunotherapy, or other biological treatments for breast cancer
- People with serious psychiatric conditions that would prevent them from giving informed consent or following the study's treatment and check-up schedule
- People who are pregnant, breastfeeding, or planning to become pregnant in the near future
- People with other significant health conditions or abnormal test results that, in the treating doctor's judgment, would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Invasive Disease Free Survival (IDFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.